Costs of new treatments for hepatitis C infection
JAMA
.
2014 Nov 26;312(20):2168.
doi: 10.1001/jama.2014.14337.
Authors
Ruth Lopert
1
,
Craig Welch
2
Affiliations
1
Department of Health Policy, George Washington University, Washington, DC.
2
LWC Health Pty Ltd, Canberra, Australia.
PMID:
25423228
DOI:
10.1001/jama.2014.14337
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents / economics*
Drug Costs*
Hepatitis C, Chronic / drug therapy*
Humans
Substances
Antiviral Agents